A Clinical Trial of Bomedemstat in Participants With Polycythemia Vera (MK-3543-025)

NCT07722611 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

380

Enrollment

INDUSTRY

Sponsor class

Conditions

Polycythemia Vera

Interventions

DRUG: Bomedemstat
DRUG: Ruxolitinib
DRUG: Ropeginterferon alfa-2b

Sponsor

Merck Sharp & Dohme LLC